# Abbvie Ireland NL B.V. – FDA Inspection, Dec 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/abbvie-ireland-nl-bv/ecd3cdcc-9f69-4553-b801-84bc390d600e
Source feed: FDA_Inspections

> FDA inspection 1253298 of Abbvie Ireland NL B.V., December 14, 2022. Classification: Voluntary Action Indicated (VAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1253298
- Company Name: Abbvie Ireland NL B.V.
- Inspection Date: 2022-12-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1124019 - 2020-02-28
- [FDA Inspection 1105474 - 2019-08-29](https://www.keypedia.com/records/fda_inspections/abbvie-ireland-nl-bv/a89be99f-7bd4-47f7-b2b1-2622fe0dea97)
- FDA Inspection 1000859 - 2017-01-20
- FDA Inspection 899864 - 2014-09-12
- FDA Inspection 717041 - 2011-03-24

Company: https://www.keypedia.com/companies/abbvie-ireland-nl-bv/d0befdd3-e659-4b7f-8c3c-4bd81f8270f2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c